Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanqi Medicinal Liquor for rheumatoid arthritis
ChiCTR1800015404Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Zhejiang Chinese Medicine University
- Start
- Jan 2018
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of panax notoginseng in rheumatoid arthritis (RA), sponsored by The Second Affiliated Hospital of Zhejiang Chinese Medicine University. Primary endpoint: DAS28 score at week 24. Started Jan 2018; status: recruiting.
02
Drugs
panax notoginseng
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR1800015404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015404.